At a glance

ClinicalIndex Comparison Record

N/ACompleted· 173 enrolled

Drug / intervention

Lopinavir / ritonavir +1 moredrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01662336

NCT01662336N/ACompleted

Compare CT.gov

Real-Life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program: A Prospective Observational Cohort Study (KASA PMOS)

AbbVie (prior sponsor, Abbott)·observational·Posted Aug 10, 2012·Updated Jan 29, 2018

In Brief

An observational study evaluating Lopinavir / ritonavir and Kaletra Adherence Support Assistance Program for Human Immunodeficiency Virus Infection. Completed, enrolled 173 participants.

Detailed Summary

The overall purpose of the study was to describe the real-life adherence, effectiveness and safety of the Kaletra Adherence Support Assistance (KASA) Program in human immunodeficiency virus (HIV)-positive patients who were receiving treatment with lopinavir / ritonavir (LPV/r; Kaletra®) in Canada.

Study Details

Study Typeobservational

Allocation--

Masking--

Primary Purpose--

ConditionsHuman Immunodeficiency Virus Infection

Countries--

Collaborators--

Timeline

N/ACompletedFinished

20132014201520162017201820192020202120222023202420252026

Enrollment StartJun 2012

First PostedAug 2012

Primary CompletionJun 2016

TodayJul 2026

First PostedAug 10, 2012

Enrollment StartJun 1, 2012

Primary CompletionJun 1, 2016

TodayJul 2, 2026

Enrollment to primary: 4 yearsPosted 13.9 years ago

Interventions

Lopinavir / ritonavirdrug

Prescribed according to the product monograph and physician's discretion.

Kaletra Adherence Support Assistance Programbehavioral

A customized support network for patients treated with lopinavir / ritonavir that offers individual counseling with an HIV experienced nurse who assists patients with various aspects of their therapy including life-style changes, emotional stress, and adverse events, and may provide access to various healthcare professionals or may offer other types of support such as transportation, exercise, etc.